Monoclonal Antibody Product types and Targeted Immunomodulation...

adicionou um novo artigo Health

2025-12-13 10:19:32 -

Monoclonal Antibody Product types and Targeted Immunomodulation Technologies: A Safety Comparison Driving Therapeutic Use cases

The treatment landscape for IgG4-Related Disease (IgG4-RD) is increasingly focusing on advanced biological therapies, with monoclonal antibody Product types leading the charge. These therapies, which represent targeted immunomodulation Technologies, aim to selectively deplete or modulate the B-cells and plasma cells responsible for the production of the pathogenic IgG4...

0 Comentários 0 Compartilhamentos 38 Visualizações 0 Anterior